XML 85 R80.htm IDEA: XBRL DOCUMENT v3.20.1
Income Taxes - Deferred Tax Assets And Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Significant components of the Company's deferred tax assets and liabilities    
Intangible assets $ 1,197 $ 1,146
Deferred revenue 8,027 9,304
Interest expense 11,299 5,239
Other reserves and accruals 699 592
Tax credit carryforwards 3,843 3,065
Amortization of stock-based compensation 9,081 8,442
Non-Compensatory Warrants 4,322 3,597
Capitalized research & development expenditures 27,084 23,410
Right Of Use Liability (Operating Leases) 39,237 16,715
Net operating loss carryforwards 64,523 58,364
Total deferred tax asset 169,312 129,874
Valuation allowance (117,353) (100,493)
Net deferred tax assets 51,959 29,381
Intangible assets (15) (37)
Convertible debt (7,718) (9,217)
Right Of Use Liability (Operating Leases) (40,298) (18,066)
Other reserves and accruals (16) (20)
Property, plant and equipment and right of use assets (3,912) (2,041)
Deferred tax liability (51,959) (29,381)
U.S.    
Significant components of the Company's deferred tax assets and liabilities    
Deferred revenue 7,898 9,304
Interest expense 11,299 5,239
Other reserves and accruals 699 592
Tax credit carryforwards 2,590 1,865
Amortization of stock-based compensation 9,081 8,442
Non-Compensatory Warrants 4,322 3,597
Capitalized research & development expenditures 22,601 19,116
Right Of Use Liability (Operating Leases) 39,237 16,715
Net operating loss carryforwards 54,947 49,058
Total deferred tax asset 152,674 113,928
Valuation allowance (100,731) (84,567)
Net deferred tax assets 51,943 29,361
Intangible assets (15) (37)
Convertible debt (7,718) (9,217)
Right Of Use Liability (Operating Leases) (40,298) (18,066)
Property, plant and equipment and right of use assets (3,912) (2,041)
Deferred tax liability (51,943) (29,361)
Foreign    
Significant components of the Company's deferred tax assets and liabilities    
Intangible assets 1,197 1,146
Deferred revenue 129  
Tax credit carryforwards 1,253 1,200
Capitalized research & development expenditures 4,483 4,294
Net operating loss carryforwards 9,576 9,306
Total deferred tax asset 16,638 15,946
Valuation allowance (16,622) (15,926)
Net deferred tax assets 16 20
Other reserves and accruals (16) (20)
Deferred tax liability $ (16) $ (20)